Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03889912
Title Pre-Operative Cemiplimab Administered Intralesionally for Patients With Recurrent Cutaneous Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Medical Dermatology Specialists RECRUITING Phoenix Arizona 85006 United States Details
Regeneron Research Facility WITHDRAWN Redwood City California 94063 United States Details
Therapeutics Clinical Research RECRUITING San Diego California 92123 United States Details
Dermatology Associates of the Palm Beaches RECRUITING Delray Beach Florida 33445 United States Details
Regeneron Research Facility COMPLETED Tampa Florida 33612 United States Details
Regeneron Research Facility RECRUITING Atlanta Georgia 30342 United States Details
Regeneron Research Facility COMPLETED Louisville Kentucky 40202 United States Details
Northeast Dermatology Associates COMPLETED Beverly Massachusetts 01915 United States Details
NYU Langone RECRUITING New York New York 10017 United States Details
Rochester Dermatologic Surgery RECRUITING Victor New York 14564 United States Details
Duke Cancer Center COMPLETED Durham North Carolina 27710 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
INOVA Schar Cancer Institute RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field